Last update:
Oncology news
A common cholesterol drug may weaken ovarian cancer's hidden shield
Ascites—the buildup of liquid in the belly—may be doing more than causing discomfort. A Duke University School of Medicine study finds this fluid helps cancer cells survive and spread—and that a decades-old cholesterol drug ...
15 hours ago
0
6
Slow-dividing breast cancer cells may explain relapses decades after treatment
A new study by the Garvan Institute of Medical Research has uncovered a hidden mechanism explaining why breast cancer can return many years after successful treatment. Published in Nature Communications, the research reveals ...
16 hours ago
0
8
Testosterone treatment found to improve sexual and physical function for men after prostate cancer surgery
Most men with low-grade prostate cancer have an excellent prognosis, with a five-year survival rate of more than 99%. But radical prostatectomy—surgery to remove the prostate—can lead to sexual and physical dysfunction, fatigue, ...
7 hours ago
0
2
Cycling may boost stem cell donation with targeted cell release, pilot study suggests
A blood stem cell donation can save the lives of people with leukemia. To collect these cells from the bloodstream, donors are given medication that mobilizes blood stem cells from the bone marrow. A pilot study now suggests ...
8 hours ago
0
1
Single screening sigmoidoscopy linked to lower colorectal cancer risk two decades later
A randomized controlled trial of adults in Norway found that a single screening sigmoidoscopy led to a sustained reduction in colorectal cancer (CRC) incidence for more than two decades after screening, with women seeing ...
9 hours ago
0
2
FDA green lights Bizengri drug to treat rare, aggressive bile duct cancer
The U.S. Food and Drug Administration (FDA) has approved Bizengri to treat an ultra-rare, aggressive cancer that forms in the bile ducts.
9 hours ago
0
1
Depression may be overdiagnosed in patients with ovarian cancer
People with ovarian cancer could be being overdiagnosed with depression due to the physical symptoms they experience as part of the cancer, according to international researchers. In addition to causing mental symptoms such ...
15 hours ago
0
3
Public education key in new cervical cancer screening
As Canada moves to modernize cervical cancer screening, a new study suggests most women do not yet understand or trust the shift from the Pap test to human papillomavirus (HPV) based screening. The national survey, published ...
May 9, 2026
0
2
Urine test outperforms MRI for monitoring low-risk prostate cancer in new study
A new urine test performed better than PSA-based testing and MRI for monitoring low-risk prostate cancers on active surveillance. Use of the test to determine the need for repeat "monitoring" biopsies would have avoided up ...
May 8, 2026
0
14
IL-10 gene therapy boosts immune attack against liver cancer in mice
Researchers at National Taiwan University have developed a liver-directed IL-10 gene therapy that strengthens cancer-fighting immune cells and suppresses liver tumors in mice. The treatment also generated long-lasting immune ...
May 8, 2026
0
7
Technology receives FDA approval for breast cancer treatment
More than a decade ago, Yale chemist Craig Crews founded a biotechnology company in New Haven based on his pioneering research into PROTACs (or PROteolysis TArgeting Chimera), a technology that treats certain types of cancer ...
May 8, 2026
0
9
Immunologist's lab demonstrates the power of B cells to gather and defend organs against cancer
Creativity and curiosity have always been central to the work of Joshua Moreau, Ph.D., an immunologist whose work at Oregon Health & Science University sits at the intersection of harnessing the immune system; delving into ...
May 8, 2026
0
3
Solving a 15-year mystery: Scientists discover how gut bacteria toxin invades colon cells to trigger cancer
Since a landmark 2009 study, researchers have known that a common gut bacterium, Bacteroides fragilis, drives colon tumor formation, potentially leading to colorectal cancer, by secreting a toxin that damages the lining of ...
May 7, 2026
0
31
Despite breakthroughs, many go without treatment for metastatic lung cancer
About half of people diagnosed with metastatic non-small-cell lung cancer never receive treatment, despite advances in options over recent decades that have created meaningful improvements in lifespan and quality of life ...
May 7, 2026
0
21
Leukemia stem cells cause treatments to fail, but findings open new avenues to overcome resistance
Scientists from the German Cancer Research Center (DKFZ) and the HI-STEM Stem Cell Institute have deciphered a key mechanism that contributes to treatment failure in acute myeloid leukemia (AML). They show that there are ...
May 7, 2026
0
10
Study identifies new strategy to overcome immunotherapy resistance in colorectal cancer
Researchers at the Icahn School of Medicine at Mount Sinai and the Mount Sinai Tisch Cancer Center have identified a promising new strategy to overcome resistance to immunotherapy in colorectal cancer, one of the leading ...
May 7, 2026
0
9
Cancer cells are better able to resist treatments when they have an abnormal number of chromosomes
A new study led by NYU Langone Health researchers has found that cancer cells are better able to resist treatments when they have an abnormal number of chromosomes, the DNA strands wound up in bundles that control which genetic ...
May 7, 2026
0
5
Why unusually long telomeres could raise lymphoma risk and reshape cancer monitoring
Researchers at the Johns Hopkins Kimmel Cancer Center and the Telomere Clinic at Johns Hopkins have identified a genetic syndrome in which unusually long telomeres—the protective caps at the ends of chromosomes—allow immune ...
May 7, 2026
0
9
RAS(ON) inhibitor daraxonrasib shows promising results in advanced pancreatic cancer
The targeted RAS inhibitor daraxonrasib was found to be safe and showed signs of efficacy in patients with previously treated RAS-mutant metastatic pancreatic cancer, according to a Phase I/II first-in-human trial led by ...
May 7, 2026
0
4
National study examines genetic testing to inform follow-up care for cancer survivors
Hundreds of thousands of people diagnosed with cancer are still alive today but were never genetically tested, either because testing was not available or was not routinely offered at the time of their diagnosis. These patients ...
May 7, 2026
0
3
Combination therapy with stem cell-derived immune cells boosts anti-cancer response
Cancer immunotherapy is built on a simple but powerful idea: the immune system can recognize and destroy cancer cells if it is properly activated. In many patients, however, this response is too weak or too slow to be effective. ...
May 7, 2026
0
3
New ultrasonic needle yields samples 2–3 times larger, potentially reshaping cancer diagnostics
Developed at Aalto University over several years, a new ultrasonic needle for tumor diagnostics has been trialed in collaboration with Helsinki University Hospital (HUS). According to the resulting peer-reviewed study, salivary ...
May 7, 2026
0
3
Lung cancer screening rates up, yet remain low
A new University of Kentucky Markey Cancer Center study published in JAMA Internal Medicine found that lung cancer screening rates among eligible U.S. adults have improved in recent years, but fewer than one in four are getting ...
May 7, 2026
0
2
Testosterone suppresses brain tumor growth in males, study suggests
In a new study, scientists at Cleveland Clinic discovered that hormones associated with male development may play a key role in limiting the growth of brain tumors in men. The research team found that the loss of androgen ...
May 6, 2026
0
27
New MRI technology maps 20-plus brain biomarkers in a single 14-minute scan
New multiplexed imaging technology using standard clinical MRI systems can simultaneously map more than 20 biomarkers in high resolution, providing a comprehensive view of the brain with a single scan.
May 6, 2026
0
20
